State Street Corp Travere Therapeutics, Inc. Transaction History

State Street Corp

  • $2.36 Trillion
  • Q1 2025

A detailed history of State Street Corp transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 3,646,715 shares of TVTX stock, worth $59.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,646,715
Previous 3,767,235 3.2%
Holding current value
$59.6 Million
Previous $65.6 Million 0.42%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$17.07 - $23.75 $2.06 Million - $2.86 Million
-120,520 Reduced 3.2%
3,646,715 $65.3 Million
Q4 2024

Feb 14, 2025
BUY
$13.65 - $19.85 $14.1 Million - $20.5 Million
1,030,539 Added 37.66%
3,767,235 $65.6 Million
Q3 2024

Nov 14, 2024
SELL
$7.89 - $15.21 $6.11 Million - $11.8 Million
-773,981 Reduced 22.05%
2,736,696 $38.3 Million
Q2 2024

Aug 14, 2024
SELL
$5.26 - $8.28 $16.3 Million - $25.7 Million
-3,098,019 Reduced 46.88%
3,510,677 $28.9 Million
Q1 2024

May 15, 2024
BUY
$7.18 - $9.82 $9.02 Million - $12.3 Million
1,256,351 Added 23.47%
6,608,696 $51 Million
Q4 2023

Feb 14, 2024
BUY
$5.44 - $9.5 $5.21 Million - $9.09 Million
957,088 Added 21.78%
5,352,345 $48.1 Million
Q3 2023

Nov 14, 2023
SELL
$7.64 - $17.25 $10.2 Million - $23.1 Million
-1,337,379 Reduced 23.33%
4,395,257 $39.3 Million
Q2 2023

Aug 14, 2023
BUY
$15.3 - $22.61 $20.9 Million - $30.9 Million
1,364,759 Added 31.25%
5,732,636 $88.1 Million
Q1 2023

May 15, 2023
BUY
$17.82 - $22.89 $2.56 Million - $3.29 Million
143,853 Added 3.41%
4,367,877 $98.2 Million
Q4 2022

Feb 14, 2023
BUY
$18.47 - $26.14 $15 Million - $21.2 Million
810,609 Added 23.75%
4,224,024 $88.8 Million
Q3 2022

Nov 15, 2022
SELL
$22.91 - $28.63 $4.44 Million - $5.55 Million
-193,750 Reduced 5.37%
3,413,415 $84.1 Million
Q2 2022

Aug 15, 2022
BUY
$20.94 - $30.01 $13.6 Million - $19.4 Million
647,804 Added 21.89%
3,607,165 $87.4 Million
Q1 2022

May 16, 2022
BUY
$23.61 - $30.6 $1.71 Million - $2.21 Million
72,284 Added 2.5%
2,959,361 $76.3 Million
Q4 2021

Feb 14, 2022
BUY
$24.34 - $31.17 $2.55 Million - $3.27 Million
104,754 Added 3.76%
2,887,077 $89.6 Million
Q3 2021

Nov 15, 2021
SELL
$12.98 - $25.03 $8.72 Million - $16.8 Million
-671,536 Reduced 19.44%
2,782,323 $67.5 Million
Q2 2021

Aug 16, 2021
BUY
$14.11 - $26.4 $14.3 Million - $26.8 Million
1,014,332 Added 41.58%
3,453,859 $50.4 Million
Q1 2021

May 17, 2021
BUY
$23.37 - $31.77 $57 Million - $77.5 Million
2,439,527 New
2,439,527 $60.9 Million

Others Institutions Holding TVTX

# of Institutions
238
Shares Held
101M
Call Options Held
1.79M
Put Options Held
555K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.05B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email